Charlotte, NC-based Sealed Air Corporation, a manufacturer of food and protective packaging solutions, has agreed to be acquired by private investment firm Clayton, Dubilier & Rice (CD&R) in an ...
Clayton, Dubilier & Rice — the private investment firm behind numerous major acquisitions in the distribution sector over the past decade — has purchased a “significant” ownership position in ...
CHARLOTTE, N.C., April 9, 2026 /PRNewswire/ -- Sealed Air Corporation ("Sealed Air" or the "Company"), a leading global provider of food and protective packaging solutions, today announced the ...
This buy brings the Resideo Technologies stake to 88.4% of 13F reportable AUM as of Dec. 31, 2025. Top holdings after the filing: Resideo Technologies: $525.96 million (88.4% of AUM) Agilon Health: ...
Clayton Dubilier & Rice and TPG Inc. are in talks with private credit firms including Blue Owl Capital Inc. to line up at least $2.5 billion of debt for Covetrus, a technology company for veterinary ...
Multi-Color Corp. is planning to skip an interest payment due Thursday on some of its borrowings as the troubled label maker seeks to buy more time to negotiate a series of looming debt deadlines. The ...
Clayton Dubilier & Rice has hired Walt Bettinger, the former chief executive officer of Charles Schwab Corp., as one of Wall Street’s oldest private equity firms continues to tap the expertise of ...
CD&R, the private equity owner of Focus Financial Partners, has tapped Charles Schwab’s former CFO, Peter Crawford, as an operating advisor to help evaluate and select new investments in the financial ...
Resideo Technologies (REZI) has disclosed a new risk, in the Share Price & Shareholder Rights category. The CD&R Stockholder, holding approximately 11% of Resideo Technologies’ total voting power as ...
PARIS, Oct 11 (Reuters) - Sanofi (SASY.PA), opens new tab has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & ...
Oct 10 (Reuters) - Sanofi (SASY.PA), opens new tab is closing in on a deal to sell its consumer health unit for about 15 billion euros ($16.4 billion) to U.S. private equity firm Clayton Dubilier & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results